November 13th it was announced that VP sales EMEA Stephanie Stenhagen had purchased 247 shares and participating in the share program for management in Medistim ASA. The correct number of shares Stephanie Stenhagen purchased under the management program was 2474 shares at 161,67 per share. After the purchase she holds 2784 shares. The shares were purchased from Medistim ASA and Medistim ASA holds 55617 shares after the transaction.